Aom0498 (Adamgammadex) received China’s NMPA approval
Aomo Pharma Inc., the U.S. subsidiary of Adamerck, is a biotechnology company founded in 2000 with the mission of developing
Tag: neuromuscular blockade reversal agent
A forum for researchers, students and applicants in the field of cyclodextrin technology